The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer?
Open accessAbstract
Introduction The Eastern Cooperative Oncology Group (ECOG) score is a well known prognostic factor and almost always used to determine eligibility for clinical trials. The patient-rated performance status score (Pt-PS), section of the patient generated subjective global assessment scale, has identical criteria to the physician-rated ECOG scale (MD-PS). We compared the Pt-PS with MD-PS in patients with advanced non-small cell lung cancer and compared the effect of each rating on eligibility for a hypothetical clinical trial. Methods Consecutive patients with newly diagnosed advanced non-small cell lung cancer completed a patient generated subjective global assessment self-rated questionnaire, which was then correlated (kappa statistic) with the ECOG PS recorded at the same time. Patients were treated with standard chemotherapy. Survival was determined using Kaplan-Meier statistics. Results One hundred nine patients (M:F-54:55) were recruited. Pt-PS differed from MD-PS in 59 (54%) instances (p = 0.0001). When scores were not congruent, 41/59 (69%) patients evaluated themselves as having a worse PS than the physician's rating. Pt-PS was 0 to 1 in 60 (55%) patients whereas MD-PS was 0 to 1 in 78 (72%) patients. The functional status irrespective of evaluator was predictive of survival (p = 0.001 for MD-PS and p = 0.001 for Pt-PS). However, the median survival in those with MD-PS >/=2 was 3.3 (CI; 1.7-4.9) months whereas individuals with Pt-PS >/=2 had a median survival of 6.2 (CI…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
Bauer, J., Capra, S., & Ferguson, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601412 · Cited by 1,178
Albain, K. S., Crowley, J. J., LeBlanc, M., & Livingston, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1618 · Cited by 728
Newell, S., Sanson‐Fisher, R. W., Girgis, A., & Bonaventura, A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8<1640::aid-cncr21>3.0.co;2-# · Cited by 278
Diamond, T., Campbell, J., Bryant, C., & Lynch, W. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981015)83:8<1561::aid-cncr11>3.0.co;2-z · Cited by 246
Performance status score: do patients and their oncologists agree?
Blagden, S. P., Charman, S. C., Sharples, L. D., Magee, L. R. A., & Gilligan, D. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601231 · Cited by 219
Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer
Firat, S., Bousamra, M., Gore, E., & Byhardt, R. W. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02741-9 · Cited by 199
Ando, M., Ando, Y., Hasegawa, Y., Shimokata, K., Minami, H., Wakai, K., Ohno, Y., & Sakai, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2162 · Cited by 192
Gridelli, C., Ardizzoni, A., Le Chevalier, T., Manegold, C., Perrone, F., Thatcher, N., van Zandwijk, N., Di Maio, M., Martelli, O., & De Marinis, F. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh087 · Cited by 164
Persson, C., Sjödén, P.-O., & Glimelius, B. (1999) · Clinical Nutrition · doi:10.1016/s0261-5614(99)80054-5 · Cited by 162
Cited by
Kawaguchi, T., Takada, M., Kubo, A., Matsumura, A., Fukai, S., Tamura, A., Saito, R., Maruyama, Y., Kawahara, M., & Ignatius Ou, S.-H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181d2dcd9 · Cited by 354
Geriatric Assessment-Identified Deficits in Older Cancer Patients With Normal Performance Status
Jolly, T. A., Deal, A. M., Nyrop, K. A., Williams, G. R., Pergolotti, M., Wood, W. A., Alston, S. M., Gordon, B.-B. E., Dixon, S. A., Moore, S. G., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0247 · Cited by 234
Health-related quality of life and cancer clinical trials
Osoba, D. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010395342 · Cited by 231
Measures of Interrater Agreement
Mandrekar, J. N. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318200f983 · Cited by 221
Middleton, G., Brock, K., Savage, J., Mant, R., Summers, Y., Connibear, J., Shah, R., Ottensmeier, C., Shaw, P., Lee, S.-M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30033-3 · Cited by 165
Metadata
- Authors
- Dajczman, E., Kasymjanova, G., Kreisman, H., Swinton, N., Pepe, C., & Small, D.
- Affiliations
- Jewish General Hospital (CA)
- Corresponding author
- Dajczman, Esther
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 3
- Issue
- 10
- Pages
- 1133-1136
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2022463221
- Cited by
- 74
- References
- 18
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 6
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2618 d)
- Locations
- Journal of Thoracic Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Keywords
- ECOG performance status, Subjective Global Assessment, non-small cell lung cancer, advanced lung cancer, functional status, patient self-assessment, inclusion and exclusion criteria, prognostic factors, survival, patient-physician agreement
- MeSH terms
- Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Clinical Trials as Topic, Combined Modality Therapy, Decision Making, Eligibility Determination, Female, Humans, Lung Neoplasms, Male, Physician-Patient Relations, Prognosis, Prospective Studies, Surveys and Questionnaires, Radiotherapy Dosage, Survival Rate, Pleural Effusion, Malignant, Karnofsky Performance Status, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer? https://app.cochat.ai/papers/10.1097/jto.0b013e318186a272
- The paper
- Dajczman, E., Kasymjanova, G., Kreisman, H., Swinton, N., Pepe, C., & Small, D. (2008). Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer? Journal of Thoracic Oncology. https://doi.org/10.1097/jto.0b013e318186a272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.